Jasper Therapeutics offers $0.324 cash per warrant to retire 12,345,707 outstanding warrants, ~$4.0M max outlay

Jasper Therapeutics, Inc.

Tender offer at $0.324 in cash per warrant, without interest; warrants were issued in Jasper's September 18, 2025 underwritten public offering.
12,345,707 warrants were outstanding as of October 6, 2026; if all are tendered the company expects to pay about $4.0 million from cash on hand.
Each warrant entitles the holder to buy one share of common stock at $2.92; tendered warrants are retired and cancelled rather than resold.
Offer expires one minute after 11:59 p.m. ET on November 6, 2026, unless extended; tenders may be withdrawn any time before the deadline.
Untendered warrants stay outstanding on original terms and expire at 5:00 p.m. ET on March 18, 2030; the offer has no minimum tender condition.

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.